Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Keybanc analyst Christopher Carril initiated coverage on CAVA Group, Inc. (NYSE:CAVA) with an Overweight rating and announced a price target of $100. Cava Group shares closed at $82.32 on Tuesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Brandon Folkes initiated coverage on Zevra Therapeutics, Inc. (NASDAQ:

Full story available on Benzinga.com

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Keybanc analyst Christopher Carril initiated coverage on CAVA Group, Inc. (NYSE:CAVA) with an Overweight rating and announced a price target of $100. Cava Group shares closed at $82.32 on Tuesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Brandon Folkes initiated coverage on Zevra Therapeutics, Inc. (NASDAQ:

Full story available on Benzinga.com

 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Keybanc analyst Christopher Carril initiated coverage on CAVA Group, Inc. (NYSE:CAVA) with an Overweight rating and announced a price target of $100. Cava Group shares closed at $82.32 on Tuesday. See how other analysts view this stock.

HC Wainwright & Co. analyst Brandon Folkes initiated coverage on Zevra Therapeutics, Inc. (NASDAQ:Full story available on Benzinga.com   Read MoreAMCR, CAVA, News, OSCR, Top Initiations, XYZ, ZVRA, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, AMCR, OSCR, ZVRA, CAVA, XYZ, News, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets